New drug approved by FDA for breast cancer patients

A new drug for the treatment of breast cancer has been approved by the Food and Drug Administration.The biotech drug Perjeta, is the first medicine labeled for patients before surgery. It is for women with a form of early stage breast cancer who face a high risk of the cancer spreading to other parts of the body.